Evidence map›Paper›PMID 40376206›Full record

ArticleOTO open

Face and Neck Pilomatricoma Excision Using an Endoscope-Assisted Hairline Approach.

Ken Woo, Dong Kun Lee, Seung Hoon Woo

Abstract read
In one paragraph

Article in OTO open. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ken WooDepartment of Molecular, Cell, and Developmental Biology University of California Los Angeles Los Angeles California USA.ORCID 0000-0001-8560-1865
Dong Kun LeeDepartment of Otolaryngology-Head and Neck Surgery Dong-A University College of Medicine Busan Korea.ORCID 0000-0002-7296-1420
Seung Hoon WooDepartment of Otolaryngology-Head and Neck Surgery Dankook University School of Medicine Cheonan Korea.ORCID https://orcid.org/0000-0001-7560-1140

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Traditional transcutaneous approaches for pilomatricoma excision in the face and neck are effective but often leave conspicuous scars that compromise cosmetic outcomes. We aimed to evaluate a refined endoscope-assisted hairline approach that uses a concealed scalp incision and enhanced endoscopic visualization to improve esthetic results while maintaining surgical efficacy. Study Design: Prospective observational study. Setting: Dankook University School of Medicine, Korea. Methods: Fifty patients with benign pilomatricomas of the face and neck were prospectively enrolled and allocated into two groups. Group A (n = 25) underwent the refined endoscope-assisted hairline approach, whereas Group B (n = 25) received the conventional transcutaneous approach. Clinical data including operative time and postoperative complications were recorded. Cosmetic outcomes were objectively evaluated using standardized photographic documentation and patient satisfaction scores collected at 3 and 12 months postoperatively. Results: The mean operative time was significantly longer in Group A compared to Group B ( Conclusion: The refined endoscope-assisted hairline approach is a safe and highly effective technique for pilomatricoma excision in cosmetically sensitive facial and neck regions. This innovative method offers significant improvements in esthetic outcomes without compromising safety, representing a distinct advance over conventional methods.

Indexed as

cosmetic outcomesendoscope‐assisted hairline approachfacial surgeryminimally invasive surgeryneck surgerypilomatricoma

Identifiers

PMID40376206
PMCPMC12080212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.